Atıf İçin Kopyala
Kilicdag H., Daghoglu K., ERDOĞAN Ş., Guzel A., SENCAR L., POLAT S., ...Daha Fazla
EARLY HUMAN DEVELOPMENT, cilt.89, sa.5, ss.355-360, 2013 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
89
Sayı:
5
-
Basım Tarihi:
2013
-
Doi Numarası:
10.1016/j.earlhumdev.2012.12.002
-
Dergi Adı:
EARLY HUMAN DEVELOPMENT
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.355-360
-
Anahtar Kelimeler:
Levetiracetam, Apoptosis, Hypoxia, Ischemia, Brain injury, ANTIEPILEPTIC DRUGS, SEIZURES, NEURODEGENERATION, ENCEPHALOPATHY, TOPIRAMATE, PROTECTION, EXPOSURE
-
Çukurova Üniversitesi Adresli:
Evet
Özet
Background: Hypoxic-ischemic brain injury (HIBI) is a common cause of neonatal mortality and morbidity. The use of levetiracetam (LEV), as a potential neuroprotective in brain ischemia, receives an increasingly high attention, and it could have a crucial role in the regulation of epileptogenesis and neuroprotection. Potential effects of LEV on neuronal apoptosis in HIBI have not previously been reported in literature.